MARKET

ACOG

ACOG

Alpha Cognition
NASDAQ
8.73
-0.17
-1.91%
Closed 19:30 11/10 EST
OPEN
8.74
PREV CLOSE
8.90
HIGH
8.99
LOW
8.50
VOLUME
107.83K
TURNOVER
12.23K
52 WEEK HIGH
10.14
52 WEEK LOW
4.500
MARKET CAP
190.12M
P/E (TTM)
-8.0328
1D
5D
1M
3M
1Y
5Y
1D
*Alpha Cognition Announces Appointment of Caren Deardorf to Board
Dow Jones · 1d ago
Foghorn Therapeutics Inc. (FHTX) Q3 Earnings and Revenues Beat Estimates
NASDAQ · 1d ago
Weekly Report: what happened at ACOG last week (1102-1106)?
Weekly Report · 2d ago
Alpha Cognition Strengthens Its Board of Directors with Appointment of Caren Deardorf
Barchart · 2d ago
Alpha Cognition to Participate in Upcoming Investor Events
Barchart · 4d ago
Urogen Pharma (URGN) Reports Q3 Loss, Beats Revenue Estimates
NASDAQ · 6d ago
Press Release: Alpha Cognition to Report Third Quarter 2026 Financial Results and Provide Business Update
Dow Jones · 11/02 21:57
Weekly Report: what happened at ACOG last week (1026-1030)?
Weekly Report · 11/02 10:14
More
About ACOG
Alpha Cognition Inc. is a commercial stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI). The Company's ZUNVEYL (benzgalantamine) product is a delayed release oral tablet formulation indicated for the treatment of mild to moderate dementia of the Alzheimer’s type in adults. Its pre-clinical development programs include ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer’s disease; ALPHA-1062 sublingual formulation; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mTBI; ALPHA-0602; ALPHA-0702 & ALPHA-0802 (Progranulin and Progranulin GEM’s) for the treatment of neurodegenerative diseases including amyotrophic lateral sclerosis or Lou Gehrig’s disease and spinal muscular atrophy, and ALPHA-1062 for the treatment of acute pancreatitis.

Webull offers Alpha Cognition Inc stock information, including NASDAQ: ACOG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACOG stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ACOG stock methods without spending real money on the virtual paper trading platform.